Opportunity Information: Apply for CDC RFA PS14 1411
Apply for CDC RFA PS14 1411
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Jun 12, 2014 and posted on Jun 12, 2014.
- Applicants must submit their applications by Jul 14, 2014 Application Deadline Date July 14, 2014 on Grants.gov, 1159pm U.S. Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- International Union Against Tuberculosis and Lung Disease
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries is a CDC discretionary funding opportunity from FY 2014 that uses a cooperative agreement mechanism to strengthen tuberculosis prevention, treatment, and program performance in low-resource settings. The central idea is to improve the quality, efficiency, and overall effectiveness of TB control efforts internationally, with a clear emphasis on practical, on-the-ground program improvements rather than stand-alone research. The award is structured as a collaboration with CDC, reflecting the cooperative agreement format, where the recipient and CDC work closely on planning, technical approaches, and implementation.
The program is designed to support the International Union Against Tuberculosis and Lung Disease (IUATLD) as the primary eligible applicant. Through this award, IUATLD is expected to provide technical assistance and deliver training programs for National TB Control Programs (NTPs), non-governmental organizations (NGOs), and other relevant partners. The intent is to build capacity across countries and organizations that are responsible for TB services, so they can strengthen case management, improve program operations, and apply best practices more consistently. A major focus is ensuring that collaborative activities translate into real improvements in the implementation of TB control strategies, including for drug-resistant forms of TB.
A key priority within the scope is strengthening control programs for drug-resistant tuberculosis, specifically multidrug-resistant TB (MDR TB) and extensively drug-resistant TB (XDR TB). The announcement highlights that technical support and training can have a substantial impact on how effectively countries implement MDR/XDR TB-related activities, which often require more complex diagnostics, longer treatment regimens, stronger adherence support, and tighter program monitoring than drug-susceptible TB. In practical terms, this funding is meant to help partner programs improve how they plan services, train staff, manage treatment and follow-up, and monitor outcomes so that TB programs function more reliably and deliver better patient results.
The measurable outcome CDC ties to program progress is aligned with a performance goal of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP): increasing the percentage of TB patients, including MDR TB patients, who complete a curative course of TB treatment within 12 months of starting therapy, while recognizing that some patients need longer than 12 months. This goal points to an emphasis on treatment completion and successful program follow-through, which typically depends on strong patient support systems, robust clinical and public health coordination, accurate tracking, and the ability to address barriers such as side effects, access challenges, and loss to follow-up. The opportunity also notes that the work supports the Healthy People 2020 focus area of TB reduction, while clarifying that Healthy People 2020 requirements do not apply to foreign entities.
From an administrative and funding standpoint, this opportunity is identified as CDC RFA PS14-1411 under CFDA 93.116 (Project Grants and Cooperative Agreements for Tuberculosis Control Programs). CDC anticipated making one award, with an estimated total funding amount of $1,000,000. The award ceiling is $1,000,000 and the award floor is $200,000, and there is no cost sharing or matching requirement. The application deadline listed was July 14, 2014 (11:59 pm U.S. Eastern Time) via Grants.gov, and the opportunity was later archived on August 13, 2014. Eligible applicants are effectively limited to IUATLD as specified in the eligibility information, even though the general category is shown as "Others" with clarification in the full announcement.
For access and support, the notice directs applicants to use the "Full Announcement" link on the posting page (noting that a separate link shown is not active). It also provides a point of contact at the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700 for assistance with accessing the full announcement electronically.
Frequently Asked Questions (FAQs)
What is the "Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries" funding opportunity?
It is a CDC discretionary funding opportunity from FY 2014 focused on improving the quality, efficiency, and overall effectiveness of tuberculosis (TB) prevention and control programs in resource-limited countries. The emphasis is on practical, on-the-ground program improvements rather than stand-alone research activities.
Which agency is offering this opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What funding mechanism is used for this award?
The award uses a cooperative agreement mechanism. This means the recipient and CDC are expected to work closely together on planning, technical approaches, and implementation as part of a collaborative relationship.
What is the main purpose of the cooperative agreement?
The main purpose is to strengthen TB prevention, treatment, and program performance internationally, especially in low-resource settings, by supporting capacity building and improvements in how TB control strategies are implemented.
Is this opportunity primarily for research?
No. The description emphasizes practical program improvements and performance strengthening rather than stand-alone research.
Who is eligible to apply?
Eligible applicants are effectively limited to the International Union Against Tuberculosis and Lung Disease (IUATLD), which is identified as the primary eligible applicant in the eligibility information.
What types of activities is IUATLD expected to carry out with the funding?
IUATLD is expected to provide technical assistance and deliver training programs for National TB Control Programs (NTPs), non-governmental organizations (NGOs), and other relevant partners to strengthen TB case management, program operations, and consistent use of best practices.
Who are the intended beneficiaries or partner groups for the technical assistance and training?
The intended partner groups include National TB Control Programs (NTPs), NGOs, and other partners involved in delivering TB services and supporting TB control efforts.
What is a major technical priority area within the scope of this opportunity?
A major priority is strengthening control programs for drug-resistant TB, specifically multidrug-resistant TB (MDR TB) and extensively drug-resistant TB (XDR TB).
How does the opportunity describe the value of technical support for MDR/XDR TB?
It notes that technical support and training can substantially affect how well countries implement MDR/XDR TB activities, which often require more complex diagnostics, longer treatment regimens, stronger adherence support, and tighter program monitoring than drug-susceptible TB.
What kinds of program improvements are implied for MDR/XDR TB control?
The description points to improvements in service planning, staff training, treatment management and follow-up, adherence support, monitoring, and outcomes tracking so that MDR/XDR TB activities are implemented more reliably and produce better patient results.
What measurable outcome is tied to program progress in this opportunity?
The measurable outcome aligns with an NCHHSTP performance goal: increasing the percentage of TB patients, including MDR TB patients, who complete a curative course of TB treatment within 12 months of starting therapy, while recognizing that some patients may require longer than 12 months.
Does the opportunity acknowledge that some TB treatment takes longer than 12 months?
Yes. It explicitly recognizes that some patients need longer than 12 months to complete treatment, even while tracking progress toward completion within a 12-month timeframe.
What program elements are implied as important to improving treatment completion?
The description highlights that treatment completion typically depends on strong patient support systems, robust clinical and public health coordination, accurate tracking, and the ability to address barriers such as side effects, access challenges, and loss to follow-up.
How does this opportunity relate to Healthy People 2020?
The work supports the Healthy People 2020 focus area of TB reduction. However, it also clarifies that Healthy People 2020 requirements do not apply to foreign entities.
What is the RFA number for this opportunity?
The opportunity is identified as CDC RFA PS14-1411.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.116 (Project Grants and Cooperative Agreements for Tuberculosis Control Programs).
How many awards did CDC anticipate making?
CDC anticipated making one award.
What was the estimated total funding amount?
The estimated total funding amount was $1,000,000.
What are the award ceiling and award floor?
The award ceiling was $1,000,000 and the award floor was $200,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
What was the application deadline and submission method?
The listed application deadline was July 14, 2014 at 11:59 pm U.S. Eastern Time, and applications were to be submitted via Grants.gov.
Is this opportunity still open?
No. The opportunity was later archived on August 13, 2014.
How does the posting suggest applicants access the full announcement?
It directs applicants to use the "Full Announcement" link on the posting page and notes that a separate link shown is not active.
Who can be contacted for help accessing the full announcement electronically?
The notice provides a point of contact at the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Quagga Mussel Containment in the West
Previous opportunity: OJJDP FY2014 Smart on Juvenile Justice Technical Assistance to End Racial and Ethnic Disparities in the Juvenile Justice System
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS14 1411
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS14 1411) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Careers Opportunity Program Skills Training and Health Workforce Development of Paraprofessionals Apply for HRSA 14 144 Funding Number: HRSA 14 144 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| Tribal Public Health Capacity Building and Quality Improvement Cooperative Agreement Apply for CDC RFA OT13 130302CONT14 Funding Number: CDC RFA OT13 130302CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Parkinsons Disease Biomarker Program (PDBP) Discovery Projects (U01) Apply for PAR 14 259 Funding Number: PAR 14 259 Agency: National Institutes of Health Category: Health Funding Amount: $490,000 |
| Centers for Medical Countermeasures against Radiation Consortium (U19) Apply for RFA AI 14 055 Funding Number: RFA AI 14 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2014 Racial and Ethnic Approaches to Community Health (REACH) financed in part by Prevention and Public Health Funding Apply for CDC RFA DP14 1419PPHF14 Funding Number: CDC RFA DP14 1419PPHF14 Agency: NCCDPHP Category: Health Funding Amount: $500,000 |
| PPHF 2014 Immunization Capacity Building Assistance for Infrastructure Enhancements to Meet Interoperability Requirements financed in part by 2014 Prevention and Public Health Funds Apply for CDC RFA IP14 1404PPHF14 Funding Number: CDC RFA IP14 1404PPHF14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Methods Development in Natural Products Chemistry (R43/R44) Apply for RFA AT 15 003 Funding Number: RFA AT 15 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (STTR) (R41) Apply for RFA AT 15 002 Funding Number: RFA AT 15 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| American Indians into Psychology Apply for HHS 2014 IHS INPSY 0001 Funding Number: HHS 2014 IHS INPSY 0001 Agency: Indian Health Service Category: Health Funding Amount: $238,359 |
| PPHF 2014 Immunization Enhanced Standards Support for the Immunization Information Systems (IIS) Community Financed solely by 2014 Prevention and Public Health Funds Apply for CDC RFA IP14 1409PPHF14 Funding Number: CDC RFA IP14 1409PPHF14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| PPHF 2014 Immunization Enhance an Immunization Information System (IIS) to Interface with CDCs VTrckS Vaccine Ordering and Management System financed in part by 2014 Prevention and Public Health Funds Apply for CDC RFA IP14 1406PPHF14 Funding Number: CDC RFA IP14 1406PPHF14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Administrative Coordination Hub for the Pharmacogenomics Research Network, PGRN (U24) Apply for RFA GM 15 004 Funding Number: RFA GM 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| PPHF 2014 Lead Poisoning Prevention Childhood Lead Poisoning Prevention financed solely by 2014 Prevention and Public Health Funds Apply for CDC RFA EH14 1408PPHF14 Funding Number: CDC RFA EH14 1408PPHF14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Research Grant Program Apply for CMS 1I0 14 001 Funding Number: CMS 1I0 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 14 001 Funding Number: CMS 1H0 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Service Area Competition Apply for HRSA 15 008 Funding Number: HRSA 15 008 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 009 Funding Number: HRSA 15 009 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIMH Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp) Apply for PA 14 263 Funding Number: PA 14 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Promoting Preventive Health Services for Women Apply for HRSA 14 084 Funding Number: HRSA 14 084 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| NINDS Direct Phase II SBIR Grants to Support Exploratory Clinical Trials Apply for PAR 14 265 Funding Number: PAR 14 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS14 1411", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.